Literature DB >> 33991199

Bacillus subtilis High Cell Density Fermentation Using a Sporulation-Deficient Strain for the Production of Surfactin.

Peter Klausmann1, Katja Hennemann1, Mareen Hoffmann1, Chantal Treinen1, Moritz Aschern1, Lars Lilge1, Kambiz Morabbi Heravi1, Marius Henkel2, Rudolf Hausmann1.   

Abstract

Bacillus subtilis 3NA is a strain capable of reaching high cell densities. A surfactin producing sfp+ variant of this strain, named JABs32, was utilized in fed-batch cultivation processes. Both a glucose and an ammonia solution were fed to set a steady growth rate μ of 0.1 h-1. In this process, a cell dry weight of up to 88 g L-1 was reached after 38 h of cultivation, and surfactin titers of up to 26.5 g L-1 were detected in this high cell density fermentation process, achieving a YP/X value of 0.23 g g-1 as well as a qP/X of 0.007 g g-1 h-1. In sum, a 21-fold increase in surfactin titer was obtained compared with cultivations in shake flasks. In contrast to fed-batch operations using Bacillus subtilis JABs24, an sfp+ variant derived from B. subtilis 168, JABs32, reached an up to fourfold increase in surfactin titers using the same fed-batch protocol. Additionally, a two-stage feed process was established utilizing strain JABs32. Using an optimized mineral salt medium in this high cell density fermentation approach, after 31 h of cultivation, surfactin titers of 23.7 g L-1 were reached with a biomass concentration of 41.3 g L-1, thus achieving an enhanced YP/X value of 0.57 g g-1 as well as a qP/X of 0.018 g g-1 h-1. The mutation of spo0A locus and an elongation of AbrB in the strain utilized in combination with a high cell density fed-batch process represents a promising new route for future enhancements on surfactin production. KEY POINTS: • Utilization of a sporulation deficient strain for fed-batch operations • High cell density process with Bacillus subtilis for lipopeptide production was established • High titer surfactin production capabilities confirm highly promising future platform strain.

Entities:  

Keywords:  Bacillus subtilis; Biosurfactant; Cyclic lipopeptide; Sporulation; Surfactin

Year:  2021        PMID: 33991199     DOI: 10.1007/s00253-021-11330-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  27 in total

Review 1.  A genetic analysis of Spo0A structure and function.

Authors:  B D Green; G Olmedo; P Youngman
Journal:  Res Microbiol       Date:  1991 Sep-Oct       Impact factor: 3.992

2.  Efficient production of surfactin from xylose-rich corncob hydrolysate using genetically modified Bacillus subtilis 168.

Authors:  Fangxiang Hu; Yuyue Liu; Junzhang Lin; Weidong Wang; Shuang Li
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-14       Impact factor: 4.813

3.  Phosphorylation of Spo0A activates its stimulation of in vitro transcription from the Bacillus subtilis spoIIG operon.

Authors:  T H Bird; J K Grimsley; J A Hoch; G B Spiegelman
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

4.  Production of surfactin and fengycin by Bacillus subtilis in a bubbleless membrane bioreactor.

Authors:  François Coutte; Didier Lecouturier; Saliha Ait Yahia; Valérie Leclère; Max Béchet; Philippe Jacques; Pascal Dhulster
Journal:  Appl Microbiol Biotechnol       Date:  2010-03-11       Impact factor: 4.813

5.  In situ enhancement of surfactin biosynthesis in Bacillus subtilis using novel artificial inducible promoters.

Authors:  Song Jiao; Xu Li; Huimin Yu; Huan Yang; Xue Li; Zhongyao Shen
Journal:  Biotechnol Bioeng       Date:  2016-10-21       Impact factor: 4.530

6.  Kinetic modeling of rhamnolipid production by Pseudomonas aeruginosa PAO1 including cell density-dependent regulation.

Authors:  Marius Henkel; Anke Schmidberger; Markus Vogelbacher; Christian Kühnert; Janina Beuker; Thomas Bernard; Thomas Schwartz; Christoph Syldatk; Rudolf Hausmann
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-29       Impact factor: 4.813

7.  Modeling leucine's metabolic pathway and knockout prediction improving the production of surfactin, a biosurfactant from Bacillus subtilis.

Authors:  François Coutte; Joachim Niehren; Debarun Dhali; Mathias John; Cristian Versari; Philippe Jacques
Journal:  Biotechnol J       Date:  2015-08       Impact factor: 4.677

8.  Extracellular control of spore formation in Bacillus subtilis.

Authors:  A D Grossman; R Losick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Evaluation of surfactin synthesis in a genome reduced Bacillus subtilis strain.

Authors:  Mareen Geissler; Ines Kühle; Kambiz Morabbi Heravi; Josef Altenbuchner; Marius Henkel; Rudolf Hausmann
Journal:  AMB Express       Date:  2019-06-12       Impact factor: 3.298

10.  Towards the Anaerobic Production of Surfactin Using Bacillus subtilis.

Authors:  Mareen Hoffmann; Diana Stephanie Fernandez Cano Luna; Shengbin Xiao; Lars Stegemüller; Katharina Rief; Kambiz Morabbi Heravi; Lars Lilge; Marius Henkel; Rudolf Hausmann
Journal:  Front Bioeng Biotechnol       Date:  2020-11-26
View more
  3 in total

1.  Surfactin Shows Relatively Low Antimicrobial Activity against Bacillus subtilis and Other Bacterial Model Organisms in the Absence of Synergistic Metabolites.

Authors:  Lars Lilge; Nadine Ersig; Philipp Hubel; Moritz Aschern; Evelina Pillai; Peter Klausmann; Jens Pfannstiel; Marius Henkel; Kambiz Morabbi Heravi; Rudolf Hausmann
Journal:  Microorganisms       Date:  2022-04-05

Review 2.  Surface-Active Compounds Produced by Microorganisms: Promising Molecules for the Development of Antimicrobial, Anti-Inflammatory, and Healing Agents.

Authors:  Jéssica Araujo; Joveliane Monteiro; Douglas Silva; Amanda Alencar; Kariny Silva; Lara Coelho; Wallace Pacheco; Darlan Silva; Maria Silva; Luís Silva; Andrea Monteiro
Journal:  Antibiotics (Basel)       Date:  2022-08-16

3.  Influence of B. subtilis 3NA mutations in spo0A and abrB on surfactin production in B. subtilis 168.

Authors:  Peter Klausmann; Lars Lilge; Moritz Aschern; Katja Hennemann; Marius Henkel; Rudolf Hausmann; Kambiz Morabbi Heravi
Journal:  Microb Cell Fact       Date:  2021-09-26       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.